Kityo C, Mambule IK, Musaazi J, Sokhela S, et al. Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial. Nat Med 2025 Nov 4. doi: 10.1038/s41591-025-04041.
PMID: 41188524